Andrea Spallarossa

Genoa, 16132, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications

USP7 at the Crossroads of Ubiquitin Signaling, Cell Cycle, and Tumorigenesis.

USP7 at the Crossroads of Ubiquitin Signaling, Cell Cycle, and Tumorigenesis.

Journal: Molecules (Basel, Switzerland)
Published: September 01, 2025

Triazole-imidazo[1,2-b]pyrazoles Able to Counteract Melanoma Cell Survival Without Compromising the Viability of Healthy Keratinocytes.

Triazole-imidazo[1,2-b]pyrazoles Able to Counteract Melanoma Cell Survival Without Compromising the Viability of Healthy Keratinocytes.

Journal: International journal of molecular sciences
Published: May 23, 2025

Targeting Ubiquitin-Specific Protease 7 with Novel 5-Amino-Pyrazole Inhibitors: Design, Synthesis, and Biological Evaluation.

Targeting Ubiquitin-Specific Protease 7 with Novel 5-Amino-Pyrazole Inhibitors: Design, Synthesis, and Biological Evaluation.

Journal: ChemMedChem
Published: March 06, 2025

Antiprotozoal Activity of Highly Substituted Pyrazole and Pyrimidine Derivatives.

Antiprotozoal Activity of Highly Substituted Pyrazole and Pyrimidine Derivatives.

Journal: ChemMedChem
Published: February 24, 2025

PDE4D: A Multipurpose Pharmacological Target.

PDE4D: A Multipurpose Pharmacological Target.

Journal: International journal of molecular sciences
Published: June 26, 2024

Novel tetrasubstituted 5-Arylamino pyrazoles able to interfere with angiogenesis and Ca2+ mobilization.

Novel tetrasubstituted 5-Arylamino pyrazoles able to interfere with angiogenesis and Ca2+ mobilization.

Journal: European journal of medicinal chemistry
Published: May 22, 2024

A Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo-Pyrazole Treatment in SKMEL-28 Melanoma Cells.

A Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo-Pyrazole Treatment in SKMEL-28 Melanoma Cells.

Journal: International journal of molecular sciences
Published: April 30, 2024

Investigations of Antioxidant and Anti-Cancer Activities of 5-Aminopyrazole Derivatives.

Investigations of Antioxidant and Anti-Cancer Activities of 5-Aminopyrazole Derivatives.

Journal: Molecules (Basel, Switzerland)
Published: April 04, 2024

Structure-Activity Relationship Studies on Highly Functionalized Pyrazole Hydrazones and Amides as Antiproliferative and Antioxidant Agents.

Structure-Activity Relationship Studies on Highly Functionalized Pyrazole Hydrazones and Amides as Antiproliferative and Antioxidant Agents.

Journal: International journal of molecular sciences
Published: March 29, 2024

New Pyrazolyl Thioureas Active against the Staphylococcus Genus.

New Pyrazolyl Thioureas Active against the Staphylococcus Genus.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 27, 2023

Cyclic diacyl thioureas enhance activity of corrector Lumacaftor on F508del-CFTR.

Cyclic diacyl thioureas enhance activity of corrector Lumacaftor on F508del-CFTR.

Journal: ChemMedChem
Published: July 26, 2023

Indole Antitumor Agents in Nanotechnology Formulations: An Overview.

Indole Antitumor Agents in Nanotechnology Formulations: An Overview.

Journal: Pharmaceutics
Published: May 30, 2023
Showing 1-12 of 40

Last Updated: 09/26/2026